1. Home
  2. XPOF vs ADAG Comparison

XPOF vs ADAG Comparison

Compare XPOF & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xponential Fitness Inc.

XPOF

Xponential Fitness Inc.

HOLD

Current Price

$3.73

Market Cap

205.6M

ML Signal

HOLD

Logo Adagene Inc.

ADAG

Adagene Inc.

HOLD

Current Price

$3.00

Market Cap

222.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XPOF
ADAG
Founded
2017
2011
Country
United States
China
Employees
N/A
128
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
205.6M
222.2M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
XPOF
ADAG
Price
$3.73
$3.00
Analyst Decision
Hold
Strong Buy
Analyst Count
6
4
Target Price
$8.13
★ $8.25
AVG Volume (30 Days)
★ 638.3K
207.2K
Earning Date
05-07-2026
04-01-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 35.24
N/A
EPS
N/A
★ N/A
Revenue
★ $11,092,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$6.63
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$3.57
$1.44
52 Week High
$9.25
$4.85

Technical Indicators

Market Signals
Indicator
XPOF
ADAG
Relative Strength Index (RSI) 32.43 33.30
Support Level N/A $2.78
Resistance Level $6.15 $3.19
Average True Range (ATR) 0.26 0.27
MACD -0.00 -0.04
Stochastic Oscillator 14.08 0.00

Price Performance

Historical Comparison
XPOF
ADAG

About XPOF Xponential Fitness Inc.

Xponential Fitness Inc is a franchisor of boutique health and wellness brands. It operates a diversified platform of five brands spanning across verticals, including Pilates, barre, stretching, functional training, and yoga. Through its subsidiary, it offers an energetic, accessible, and personalized workout experience led by qualified instructors in studio locations throughout North America and internationally. The company's portfolio of brands includes Club Pilates; StretchLab; YogaSix; Pure Barre; and BFT. It operates in a single segment of the franchise business of its health and wellness brands.

About ADAG Adagene Inc.

Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies. The Company leverages computational biology to design and develop novel antibodies. Powered by its Dynamic Precision Library (DPL) platform, which fuels its NEObody, SAFEbody, and POWERbody technologies, it is developing a pipeline of immunotherapies. Its candidate, ADG126 (muzastotug), an anti-CTLA-4 SAFEbody, is in phase 1b/2 and phase 2 clinical development for metastatic microsatellite-stable colorectal cancer. Its clinical-stage products include ADG126 and ADG116, investigational fully human anti-CTLA-4 mAbs generated through SAFEbody and NEObody technologies.

Share on Social Networks: